세계의 탈회골 매트릭스 시장 규모, 점유율, 동향 분석 리포트 : 최종 용도별, 제품 유형별, 용도별, 지역별 전망과 예측(2023-2030년)

Global Demineralized Bone Matrix Market Size, Share & Trends Analysis Report By End-use (Outpatient Facilities, and Hospitals), By Product Type (Putty, Fiber, Sponge, Paste, Gel, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2030

US $ 3,600 ￦ 5,201,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,241,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,738,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 탈회골 매트릭스 시장 규모는 2030년까지 19억 달러에 달할 것으로 예상되고 있으며, 예측 기간 중 5.6%의 CAGR로 시장 성장이 전망됩니다.

또한 추간판 퇴행성 질환, 척추관 협착증, 척추 골절과 같은 척추 질환은 고령화 및 좌식 생활습관 등의 요인으로 인해 전 세계에서 확산되고 있습니다. 이러한 증상을 치료하기 위해 척추 고정술이 일반적으로 시행되며, DBM은 척추 고정을 촉진하고 척추를 안정화시키기 위한 골이식 대체물 또는 익스텐더로 자주 사용됩니다. 결론적으로, 척추 고정술 및 치과 수술 건수 증가가 시장 성장을 주도하고 있습니다.

그러나 탈회골 매트릭스의 제조에는 탈회, 멸균, 보존 등 복잡한 공정이 포함되며 첨단 기술과 전문 지식이 필요합니다. 이러한 제조 공정에는 막대한 비용이 소요되며, 이는 소비자에게 전가됩니다. 따라서 이와 관련된 비용 증가는 시장 성장을 저해하는 요인입니다.

팬데믹은 전 세계 공급망에 혼란을 일으켜 DBM 생산에 사용되는 인체 공여 조직의 조달, 가공 및 유통에 영향을 미쳤습니다. 이동 제한, 국경 폐쇄 및 물류 문제로 인해 조직 이식편 운송이 중단되어 공급 부족과 제품 수급 지연이 발생했습니다. 이처럼 COVID-19 팬데믹은 시장에 부정적인 영향을 미쳤습니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요약

• 주요 하이라이트

제3장 시장 개요

• 서론
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 촉진요인
  • 시장 기회
  • 시장 억제요인
  • 시장이 해결해야 할 과제
• Porter's Five Forces 분석

제4장 세계 시장 : 최종 용도별

• 세계의 외래 시설 시장 : 지역별
• 세계의 병원 시장 : 지역별

제5장 세계 시장 : 제품 유형별

• 세계의 퍼티 시장 : 지역별
• 세계의 섬유 시장 : 지역별
• 세계의 스펀지 시장 : 지역별
• 세계의 페이스트 시장 : 지역별
• 세계의 젤 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 세계 시장 : 용도별

• 세계의 척추고정술 시장 : 지역별
• 세계의 치과 시장 : 지역별
• 세계의 공동 재건 시장 : 지역별
• 세계의 손, 발, 발목 시장 : 지역별
• 세계의 장골 시장 : 지역별
• 세계의 두개악안면 시장 : 지역별

제7장 세계 시장 : 지역별

• 북미
  • 북미의 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미 지역
• 유럽
  • 유럽의 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽 지역
• 아시아태평양
  • 아시아태평양의 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카·중동 및 아프리카
  • 라틴아메리카·중동 및 아프리카의 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카·중동 및 아프리카

제8장 기업 개요

• Zimmer Biomet Holdings, Inc
• Medtronic PLC
• Johnson & Johnson
• Stryker Corporation
• Arthrex, Inc
• Globus Medical, Inc
• Berkeley Advanced Biomaterials
• Xtant Medical Holdings, Inc
• Orthofix Medical Inc
• Institut Straumann AG

제9장 탈회골 매트릭스 시장의 성공 필수 조건

KSA

영문 목차

영문목차

The Global Demineralized Bone Matrix Market size is expected to reach $1.9 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.

Demineralized bone matrix paste formulations are designed to flow and adapt to irregular bone defects, filling voids and crevices with precision. Therefore, the paste segment captured $118.9 million revenue in the market in 2022. The paste consistency allows for easy manipulation and placement, ensuring complete coverage of the defect site and optimal contact with surrounding bone tissue for effective graft integration.

Musculoskeletal disorders, such as fractures, osteoporosis, and spinal fusion-related issues, are becoming more common due to factors like aging populations, sedentary lifestyles, and sports-related injuries. As these conditions become more prevalent, the demand for effective treatments like DBM rises. Therefore, the rising prevalence of musculoskeletal disorders is fuelling the expansion of the market.

Additionally, Spinal disorders, such as degenerative disc disease, spinal stenosis, and spinal fractures, are becoming more prevalent globally due to factors like aging populations and sedentary lifestyles. Spinal fusion surgeries are commonly performed to treat these conditions, and DBM is often used as a bone graft substitute or extender to promote spinal fusion and stabilize the spine. In conclusion, the increasing volume of spinal fusion and dental surgeries is driving the market's growth.

However, producing demineralized bone matrix involves complex processes such as demineralization, sterilization, and preservation, which require advanced technology and expertise. These manufacturing processes incur significant costs, passed on to the consumers. Therefore, the elevated expense associated with this impedes the market's growth.

The pandemic led to disruptions in the global supply chain, affecting the procurement, processing, and distribution of human donor tissue used in DBM production. Restrictions on movement, border closures, and logistical challenges impeded the transportation of tissue grafts, causing supply shortages and delays in product availability. Thus, the COVID-19 pandemic had a negative impact on the market.

By End-use Analysis

Based on end-use, the market is divided into hospitals and outpatient facilities. The outpatient facilities segment attained 57.1% revenue share in the market in 2022. Outpatient facilities offer a convenient setting for patients to undergo these procedures without needing overnight hospitalization, reducing healthcare costs and improving patient satisfaction.

By Product Type Analysis

Based on product type, the market is divided into putty, fiber, sponge, paste, gel, and others. In 2022, the fiber segment held 15.9% revenue share in the market. The fibrous architecture of DBM fibers allows for interlocking with surrounding bone tissue, anchoring the graft material in place and minimizing the risk of graft migration.

By Application Analysis

Based on application, the market is categorized into spinal fusion, dental, joint reconstruction, hand, foot, & ankle, long bone, and craniomaxillofacial. In 2022, the spinal fusion segment registered 41.2% revenue share in the market. Spinal disorders such as degenerative disc disease, spinal stenosis, and vertebral fractures are increasingly prevalent, particularly among aging populations.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 24.6% revenue share in the market. The Asia Pacific region is witnessing rapid technological advancements in orthopedic and dental surgery, including the adoption of minimally invasive techniques, computer-assisted navigation, and 3D printing.

List of Key Companies Profiled

• Zimmer Biomet Holdings, Inc.
• Medtronic PLC
• Johnson & Johnson
• Stryker Corporation
• Arthrex, Inc.
• Globus Medical, Inc.
• Berkeley Advanced Biomaterials
• Xtant Medical Holdings, Inc.
• Orthofix Medical Inc.
• Institut Straumann AG

Global Demineralized Bone Matrix Market Report Segmentation

By End-use

• Outpatient Facilities
• Hospitals

By Product Type

• Putty
• Fiber
• Sponge
• Paste
• Gel
• Others

By Application

• Government
• Energy
• Defense
• Agriculture & Forestry
• Media & Entertainment
• Civil Engineering & Archaeology
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Demineralized Bone Matrix Market, by End-use
  • 1.4.2Global Demineralized Bone Matrix Market, by Product Type
  • 1.4.3Global Demineralized Bone Matrix Market, by Application
  • 1.4.4Global Demineralized Bone Matrix Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global Demineralized Bone Matrix Market by End-use

• 4.1Global Outpatient Facilities Market by Region
• 4.2Global Hospitals Market by Region

Chapter 5.Global Demineralized Bone Matrix Market by Product Type

• 5.1Global Putty Market by Region
• 5.2Global Fiber Market by Region
• 5.3Global Sponge Market by Region
• 5.4Global Paste Market by Region
• 5.5Global Gel Market by Region
• 5.6Global Others Market by Region

Chapter 6.Global Demineralized Bone Matrix Market by Application

• 6.1Global Spinal Fusion Market by Region
• 6.2Global Dental Market by Region
• 6.3Global Joint Reconstruction Market by Region
• 6.4Global Hand, Foot, & Ankle Market by Region
• 6.5Global Long Bone Market by Region
• 6.6Global Craniomaxillofacial Market by Region

Chapter 7.Global Demineralized Bone Matrix Market by Region

• 7.1North America Demineralized Bone Matrix Market
  • 7.1.1North America Demineralized Bone Matrix Market by End-use
    • 7.1.1.1North America Outpatient Facilities Market by Region
    • 7.1.1.2North America Hospitals Market by Region
  • 7.1.2North America Demineralized Bone Matrix Market by Product Type
    • 7.1.2.1North America Putty Market by Country
    • 7.1.2.2North America Fiber Market by Country
    • 7.1.2.3North America Sponge Market by Country
    • 7.1.2.4North America Paste Market by Country
    • 7.1.2.5North America Gel Market by Country
    • 7.1.2.6North America Others Market by Country
  • 7.1.3North America Demineralized Bone Matrix Market by Application
    • 7.1.3.1North America Spinal Fusion Market by Country
    • 7.1.3.2North America Dental Market by Country
    • 7.1.3.3North America Joint Reconstruction Market by Country
    • 7.1.3.4North America Hand, Foot, & Ankle Market by Country
    • 7.1.3.5North America Long Bone Market by Country
    • 7.1.3.6North America Craniomaxillofacial Market by Country
  • 7.1.4North America Demineralized Bone Matrix Market by Country
    • 7.1.4.1US Demineralized Bone Matrix Market
      • 7.1.4.1.1US Demineralized Bone Matrix Market by End-use
      • 7.1.4.1.2US Demineralized Bone Matrix Market by Product Type
      • 7.1.4.1.3US Demineralized Bone Matrix Market by Application
    • 7.1.4.2Canada Demineralized Bone Matrix Market
      • 7.1.4.2.1Canada Demineralized Bone Matrix Market by End-use
      • 7.1.4.2.2Canada Demineralized Bone Matrix Market by Product Type
      • 7.1.4.2.3Canada Demineralized Bone Matrix Market by Application
    • 7.1.4.3Mexico Demineralized Bone Matrix Market
      • 7.1.4.3.1Mexico Demineralized Bone Matrix Market by End-use
      • 7.1.4.3.2Mexico Demineralized Bone Matrix Market by Product Type
      • 7.1.4.3.3Mexico Demineralized Bone Matrix Market by Application
    • 7.1.4.4Rest of North America Demineralized Bone Matrix Market
      • 7.1.4.4.1Rest of North America Demineralized Bone Matrix Market by End-use
      • 7.1.4.4.2Rest of North America Demineralized Bone Matrix Market by Product Type
      • 7.1.4.4.3Rest of North America Demineralized Bone Matrix Market by Application
• 7.2Europe Demineralized Bone Matrix Market
  • 7.2.1Europe Demineralized Bone Matrix Market by End-use
    • 7.2.1.1Europe Outpatient Facilities Market by Country
    • 7.2.1.2Europe Hospitals Market by Country
  • 7.2.2Europe Demineralized Bone Matrix Market by Product Type
    • 7.2.2.1Europe Putty Market by Country
    • 7.2.2.2Europe Fiber Market by Country
    • 7.2.2.3Europe Sponge Market by Country
    • 7.2.2.4Europe Paste Market by Country
    • 7.2.2.5Europe Gel Market by Country
    • 7.2.2.6Europe Others Market by Country
  • 7.2.3Europe Demineralized Bone Matrix Market by Application
    • 7.2.3.1Europe Spinal Fusion Market by Country
    • 7.2.3.2Europe Dental Market by Country
    • 7.2.3.3Europe Joint Reconstruction Market by Country
    • 7.2.3.4Europe Hand, Foot, & Ankle Market by Country
    • 7.2.3.5Europe Long Bone Market by Country
    • 7.2.3.6Europe Craniomaxillofacial Market by Country
  • 7.2.4Europe Demineralized Bone Matrix Market by Country
    • 7.2.4.1Germany Demineralized Bone Matrix Market
      • 7.2.4.1.1Germany Demineralized Bone Matrix Market by End-use
      • 7.2.4.1.2Germany Demineralized Bone Matrix Market by Product Type
      • 7.2.4.1.3Germany Demineralized Bone Matrix Market by Application
    • 7.2.4.2UK Demineralized Bone Matrix Market
      • 7.2.4.2.1UK Demineralized Bone Matrix Market by End-use
      • 7.2.4.2.2UK Demineralized Bone Matrix Market by Product Type
      • 7.2.4.2.3UK Demineralized Bone Matrix Market by Application
    • 7.2.4.3France Demineralized Bone Matrix Market
      • 7.2.4.3.1France Demineralized Bone Matrix Market by End-use
      • 7.2.4.3.2France Demineralized Bone Matrix Market by Product Type
      • 7.2.4.3.3France Demineralized Bone Matrix Market by Application
    • 7.2.4.4Russia Demineralized Bone Matrix Market
      • 7.2.4.4.1Russia Demineralized Bone Matrix Market by End-use
      • 7.2.4.4.2Russia Demineralized Bone Matrix Market by Product Type
      • 7.2.4.4.3Russia Demineralized Bone Matrix Market by Application
    • 7.2.4.5Spain Demineralized Bone Matrix Market
      • 7.2.4.5.1Spain Demineralized Bone Matrix Market by End-use
      • 7.2.4.5.2Spain Demineralized Bone Matrix Market by Product Type
      • 7.2.4.5.3Spain Demineralized Bone Matrix Market by Application
    • 7.2.4.6Italy Demineralized Bone Matrix Market
      • 7.2.4.6.1Italy Demineralized Bone Matrix Market by End-use
      • 7.2.4.6.2Italy Demineralized Bone Matrix Market by Product Type
      • 7.2.4.6.3Italy Demineralized Bone Matrix Market by Application
    • 7.2.4.7Rest of Europe Demineralized Bone Matrix Market
      • 7.2.4.7.1Rest of Europe Demineralized Bone Matrix Market by End-use
      • 7.2.4.7.2Rest of Europe Demineralized Bone Matrix Market by Product Type
      • 7.2.4.7.3Rest of Europe Demineralized Bone Matrix Market by Application
• 7.3Asia Pacific Demineralized Bone Matrix Market
  • 7.3.1Asia Pacific Demineralized Bone Matrix Market by End-use
    • 7.3.1.1Asia Pacific Outpatient Facilities Market by Country
    • 7.3.1.2Asia Pacific Hospitals Market by Country
  • 7.3.2Asia Pacific Demineralized Bone Matrix Market by Product Type
    • 7.3.2.1Asia Pacific Putty Market by Country
    • 7.3.2.2Asia Pacific Fiber Market by Country
    • 7.3.2.3Asia Pacific Sponge Market by Country
    • 7.3.2.4Asia Pacific Paste Market by Country
    • 7.3.2.5Asia Pacific Gel Market by Country
    • 7.3.2.6Asia Pacific Others Market by Country
  • 7.3.3Asia Pacific Demineralized Bone Matrix Market by Application
    • 7.3.3.1Asia Pacific Spinal Fusion Market by Country
    • 7.3.3.2Asia Pacific Dental Market by Country
    • 7.3.3.3Asia Pacific Joint Reconstruction Market by Country
    • 7.3.3.4Asia Pacific Hand, Foot, & Ankle Market by Country
    • 7.3.3.5Asia Pacific Long Bone Market by Country
    • 7.3.3.6Asia Pacific Craniomaxillofacial Market by Country
  • 7.3.4Asia Pacific Demineralized Bone Matrix Market by Country
    • 7.3.4.1China Demineralized Bone Matrix Market
      • 7.3.4.1.1China Demineralized Bone Matrix Market by End-use
      • 7.3.4.1.2China Demineralized Bone Matrix Market by Product Type
      • 7.3.4.1.3China Demineralized Bone Matrix Market by Application
    • 7.3.4.2Japan Demineralized Bone Matrix Market
      • 7.3.4.2.1Japan Demineralized Bone Matrix Market by End-use
      • 7.3.4.2.2Japan Demineralized Bone Matrix Market by Product Type
      • 7.3.4.2.3Japan Demineralized Bone Matrix Market by Application
    • 7.3.4.3India Demineralized Bone Matrix Market
      • 7.3.4.3.1India Demineralized Bone Matrix Market by End-use
      • 7.3.4.3.2India Demineralized Bone Matrix Market by Product Type
      • 7.3.4.3.3India Demineralized Bone Matrix Market by Application
    • 7.3.4.4South Korea Demineralized Bone Matrix Market
      • 7.3.4.4.1South Korea Demineralized Bone Matrix Market by End-use
      • 7.3.4.4.2South Korea Demineralized Bone Matrix Market by Product Type
      • 7.3.4.4.3South Korea Demineralized Bone Matrix Market by Application
    • 7.3.4.5Singapore Demineralized Bone Matrix Market
      • 7.3.4.5.1Singapore Demineralized Bone Matrix Market by End-use
      • 7.3.4.5.2Singapore Demineralized Bone Matrix Market by Product Type
      • 7.3.4.5.3Singapore Demineralized Bone Matrix Market by Application
    • 7.3.4.6Malaysia Demineralized Bone Matrix Market
      • 7.3.4.6.1Malaysia Demineralized Bone Matrix Market by End-use
      • 7.3.4.6.2Malaysia Demineralized Bone Matrix Market by Product Type
      • 7.3.4.6.3Malaysia Demineralized Bone Matrix Market by Application
    • 7.3.4.7Rest of Asia Pacific Demineralized Bone Matrix Market
      • 7.3.4.7.1Rest of Asia Pacific Demineralized Bone Matrix Market by End-use
      • 7.3.4.7.2Rest of Asia Pacific Demineralized Bone Matrix Market by Product Type
      • 7.3.4.7.3Rest of Asia Pacific Demineralized Bone Matrix Market by Application
• 7.4LAMEA Demineralized Bone Matrix Market
  • 7.4.1LAMEA Demineralized Bone Matrix Market by End-use
    • 7.4.1.1LAMEA Outpatient Facilities Market by Country
    • 7.4.1.2LAMEA Hospitals Market by Country
  • 7.4.2LAMEA Demineralized Bone Matrix Market by Product Type
    • 7.4.2.1LAMEA Putty Market by Country
    • 7.4.2.2LAMEA Fiber Market by Country
    • 7.4.2.3LAMEA Sponge Market by Country
    • 7.4.2.4LAMEA Paste Market by Country
    • 7.4.2.5LAMEA Gel Market by Country
    • 7.4.2.6LAMEA Others Market by Country
  • 7.4.3LAMEA Demineralized Bone Matrix Market by Application
    • 7.4.3.1LAMEA Spinal Fusion Market by Country
    • 7.4.3.2LAMEA Dental Market by Country
    • 7.4.3.3LAMEA Joint Reconstruction Market by Country
    • 7.4.3.4LAMEA Hand, Foot, & Ankle Market by Country
    • 7.4.3.5LAMEA Long Bone Market by Country
    • 7.4.3.6LAMEA Craniomaxillofacial Market by Country
  • 7.4.4LAMEA Demineralized Bone Matrix Market by Country
    • 7.4.4.1Brazil Demineralized Bone Matrix Market
      • 7.4.4.1.1Brazil Demineralized Bone Matrix Market by End-use
      • 7.4.4.1.2Brazil Demineralized Bone Matrix Market by Product Type
      • 7.4.4.1.3Brazil Demineralized Bone Matrix Market by Application
    • 7.4.4.2Argentina Demineralized Bone Matrix Market
      • 7.4.4.2.1Argentina Demineralized Bone Matrix Market by End-use
      • 7.4.4.2.2Argentina Demineralized Bone Matrix Market by Product Type
      • 7.4.4.2.3Argentina Demineralized Bone Matrix Market by Application
    • 7.4.4.3UAE Demineralized Bone Matrix Market
      • 7.4.4.3.1UAE Demineralized Bone Matrix Market by End-use
      • 7.4.4.3.2UAE Demineralized Bone Matrix Market by Product Type
      • 7.4.4.3.3UAE Demineralized Bone Matrix Market by Application
    • 7.4.4.4Saudi Arabia Demineralized Bone Matrix Market
      • 7.4.4.4.1Saudi Arabia Demineralized Bone Matrix Market by End-use
      • 7.4.4.4.2Saudi Arabia Demineralized Bone Matrix Market by Product Type
      • 7.4.4.4.3Saudi Arabia Demineralized Bone Matrix Market by Application
    • 7.4.4.5South Africa Demineralized Bone Matrix Market
      • 7.4.4.5.1South Africa Demineralized Bone Matrix Market by End-use
      • 7.4.4.5.2South Africa Demineralized Bone Matrix Market by Product Type
      • 7.4.4.5.3South Africa Demineralized Bone Matrix Market by Application
    • 7.4.4.6Nigeria Demineralized Bone Matrix Market
      • 7.4.4.6.1Nigeria Demineralized Bone Matrix Market by End-use
      • 7.4.4.6.2Nigeria Demineralized Bone Matrix Market by Product Type
      • 7.4.4.6.3Nigeria Demineralized Bone Matrix Market by Application
    • 7.4.4.7Rest of LAMEA Demineralized Bone Matrix Market
      • 7.4.4.7.1Rest of LAMEA Demineralized Bone Matrix Market by End-use
      • 7.4.4.7.2Rest of LAMEA Demineralized Bone Matrix Market by Product Type
      • 7.4.4.7.3Rest of LAMEA Demineralized Bone Matrix Market by Application

Chapter 8.Company Profiles

• 8.1Zimmer Biomet Holdings, Inc.
  • 8.1.1Company Overview
  • 8.1.2Financial Analysis
  • 8.1.3Segmental and Regional Analysis
  • 8.1.4Research & Development Expense
  • 8.1.5SWOT Analysis
• 8.2Medtronic PLC
  • 8.2.1Company overview
  • 8.2.2Financial Analysis
  • 8.2.3Segmental and Regional Analysis
  • 8.2.4Research & Development Expenses
  • 8.2.5Recent strategies and developments:
    • 8.2.5.1Product Launches and Product Expansions:
  • 8.2.6SWOT Analysis
• 8.3Johnson & Johnson
  • 8.3.1Company Overview
  • 8.3.2Financial Analysis
  • 8.3.3Segmental & Regional Analysis
  • 8.3.4Research & Development Expenses
  • 8.3.5SWOT Analysis
• 8.4Stryker Corporation
  • 8.4.1Company Overview
  • 8.4.2Financial Analysis
  • 8.4.3Segmental and Regional Analysis
  • 8.4.4Research & Development Expense
  • 8.4.5SWOT Analysis
• 8.5Arthrex, Inc.
  • 8.5.1Company Overview
  • 8.5.2SWOT Analysis
• 8.6Globus Medical, Inc.
  • 8.6.1Company Overview
  • 8.6.2Financial Analysis
  • 8.6.3Regional Analysis
  • 8.6.4Research & Development Expense
  • 8.6.5SWOT Analysis
• 8.7Berkeley Advanced Biomaterials
  • 8.7.1Company Overview
  • 8.7.2SWOT Analysis
• 8.8Xtant Medical Holdings, Inc.
  • 8.8.1Company Overview
  • 8.8.2Financial Analysis
  • 8.8.3Regional Analysis
  • 8.8.4Research & Development Expenses
  • 8.8.5SWOT Analysis
• 8.9Orthofix Medical Inc.
  • 8.9.1Company Overview
  • 8.9.2Financial Analysis
  • 8.9.3Segmental and Regional Analysis
  • 8.9.4Research & Development Expenses
  • 8.9.5Recent strategies and developments:
    • 8.9.5.1Partnerships, Collaborations, and Agreements:
    • 8.9.5.2Product Launches and Product Expansions:
    • 8.9.5.3Acquisition and Mergers:
  • 8.9.6SWOT Analysis
• 8.10.Institut Straumann AG
  • 8.10.1Company Overview
  • 8.10.2Financial Analysis
  • 8.10.3Regional Analysis
  • 8.10.4Research & Development Expenses
  • 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of Demineralized Bone Matrix Market

관련자료